LaserBlood Project

Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer

Mission

Pancreatic ductal adenocarcinoma is a deadly form of cancer that is on the rise due to various factors, including an aging population and unhealthy lifestyles.

• It is regrettably among the top cancer killers, with a dismal five-year survival rate of less than 10%.
• Currently, no adequate screening programs are available.

Our mission is to create a test for mass screening and reduce the mortality of this cancer by 80%.

Objective

The project LASERBLOOD aims to develop an in vitro diagnostic test based on:

• The fluorescence lifetime fingerprint of nanoparticle-coated, disease-specific markers, providing critical insights into pancreatic cancer progression.
• A non-invasive liquid biopsy for pancreatic cancer – a blood test that will detect signs of cancer at every stage.

This innovative technology will leverage fluorescence lifetime analysis – a reactant-free, real-time, laser-based technique.